Neurocrine's market cap is currently $14.08B. The company's EPS TTM is $1.06; its P/E ratio is 41.91; Neurocrine is scheduled to report earnings on July 30, 2025, and the estimated EPS forecast is $1.56. See an overview of income statement, balance sheet, and cash flow financials.
